memori
b
cell
marker
character
peripher
b
cell
phenotyp
show
divers
express
pattern
infect
central
nervou
system
cn
stimul
day
prior
elispot
analysi
achiev
optim
convers
cnsderiv
memori
b
cell
asc
minim
cell
loss
vitro
stimul
allow
simultan
assess
antibodi
secret
cell
memori
b
cell
isotyp
antigen
specif
tempor
alter
cn
inflamm
background
cn
inflamm
result
infect
injuri
neurodegener
lead
accumul
divers
b
cell
subset
although
antibodi
secret
cell
asc
within
inflam
cn
extens
examin
memori
b
cell
bmem
character
limit
secret
antibodi
without
stimul
moreov
unlik
human
bmem
reliabl
surfac
marker
murin
bmem
remain
elus
new
method
use
viral
encephalomyel
model
develop
modifi
limit
dilut
vitro
stimul
assay
convert
cnsderiv
viru
specif
bmem
asc
comparison
exist
method
stimul
method
establish
lymphoid
tissu
cell
use
prolong
stimul
viral
lysat
result
substanti
asc
loss
minim
bmem
asc
convers
cnsderiv
cell
vari
stimul
durat
tlr
activ
cultur
supplement
achiev
optim
convers
cultur
cell
agonist
presenc
feeder
cell
day
result
flow
cytometri
marker
character
murin
bmem
lymphoid
tissu
show
divers
express
pattern
correspond
cnsderiv
b
cell
subset
use
optim
stimul
protocol
compar
virusspecif
igg
bmem
versu
preexist
asc
within
brain
spinal
cord
increas
bmem
frequenc
chronic
infect
mirror
kinet
asc
howev
despit
initi
similar
bmem
asc
accumul
bmem
prevail
brain
lower
asc
spinal
cord
persist
conclus
simultan
enumer
antigenspecif
bmem
asc
use
bmem
assay
optim
cnsderiv
cell
enabl
character
tempor
chang
microbi
autoantigen
induc
neuroinflamm
antibodi
ab
secret
cell
asc
serum
ab
essenti
immun
compon
neutral
pathogen
infect
igg
bmem
independ
respons
igm
bmem
follow
initi
antigen
exposur
persist
independ
antigen
within
secondari
lymphoid
tissu
slt
year
kurosaki
et
al
taylor
et
al
although
bmem
spontan
secret
ab
minim
stimul
requir
includ
cell
help
andor
secondari
encount
antigen
trigger
rapid
differenti
antigenspecif
asc
rese
gc
therebi
promot
isotyp
switch
somat
hypermut
kurosaki
et
al
zuccarinocatania
et
al
pape
et
al
dogan
et
al
hebei
et
al
aiba
et
al
addit
contribut
longliv
humor
immun
bmem
function
potent
antigen
present
cell
immun
modul
secret
cytokin
shimoda
koni
duddi
et
al
adlowitz
et
al
lund
lino
et
al
although
studi
b
cell
within
inflam
cn
commonli
focus
asc
ab
specif
b
cell
popul
accumul
cn
infect
injuri
neurodegener
divers
includ
bmem
duddi
et
al
niino
et
al
krumbholz
et
al
michel
et
al
metcalf
griffin
cepok
et
al
phare
et
al
dang
et
al
ankeni
et
al
howev
role
bmem
within
inflam
cn
rel
unexplor
due
limit
reliabl
surfac
marker
particularli
murin
model
human
bmem
classic
distinguish
express
protein
belong
tumor
necrosi
factor
receptor
tnfr
famili
provid
signal
regul
entri
plasma
cell
lineag
klein
et
al
tangy
et
al
detail
human
bmem
phenotyp
reveal
heterogen
popul
includ
bmem
marker
expand
includ
specif
pattern
amu
et
al
sanz
et
al
panel
aid
identifi
sever
reliabl
marker
human
bmem
murin
bmem
character
limit
low
frequenc
bmem
minim
express
xiao
et
al
anderson
et
al
liu
et
al
ridderstad
tarlinton
although
sever
marker
includ
propos
defin
least
five
subset
bmem
marker
also
express
sever
b
cell
phenotyp
within
slt
zuccarinocatania
et
al
anderson
et
al
conter
et
al
tomayko
et
al
moreov
studi
murin
b
cell
subset
central
nervou
system
cn
reveal
uniqu
pattern
activ
marker
compar
peripher
b
cell
counterpart
complic
identif
cn
b
cell
subset
base
welldefin
slt
marker
disano
et
al
exampl
marker
cell
help
propos
marker
defin
subpopul
bmem
within
slt
found
multipl
b
cell
phenotyp
within
cn
disano
et
al
bmem
analysi
vivo
larg
reli
protein
immun
b
cell
receptor
bcr
transgen
mice
increas
bmem
frequenc
antigen
challeng
recipi
adopt
transfer
antigenspecif
b
cell
vitro
vivo
bmem
asc
convers
shown
requir
prolifer
slifka
ahm
cao
et
al
pinna
et
al
tangy
hodgkin
bernasconi
et
al
kometani
et
al
quantit
assess
bmem
frequenc
antigen
specif
thu
includ
lengthi
elisa
base
limit
dilut
assay
lda
requir
week
stimul
shorter
day
vitro
stimul
method
convert
bmem
asc
measur
convent
elispot
slifka
ahm
cao
et
al
pinna
et
al
amanna
slifka
jahnmatz
et
al
walsh
et
al
crotti
et
al
buisman
et
al
method
defin
bmem
antigen
specif
rel
frequenc
focus
peripher
blood
slt
use
tlr
agonist
stimul
vitro
bmem
convers
asc
best
knowledg
approach
appli
cnsderiv
bmem
expos
vastli
distinct
microenviron
prolong
isol
procedur
lymphocyt
cn
well
prior
vivo
exposur
toxic
factor
may
requir
finetun
method
defin
bmem
kinet
specif
cn
infect
injuri
neurodegener
present
studi
analyz
bmem
marker
express
cn
infiltr
b
cell
optim
vitro
stimul
method
enumer
virusspecif
bmem
cn
use
neurotrop
coronaviru
jmhvinduc
encephalomyel
model
viru
introduc
brain
spread
spinal
cord
wang
et
al
although
cell
clear
infecti
viru
organ
within
day
post
infect
pi
viru
establish
persist
character
low
level
persist
viral
rna
elev
level
chemokin
cytokin
predominantli
spinal
cord
phare
et
al
asc
emerg
within
cn
initi
viral
control
maintain
persist
viral
rna
low
level
prevent
viral
recrudesc
lin
et
al
marqu
et
al
isotypeunswitch
igg
b
cell
accumul
earli
infect
progress
replac
differenti
igd
igm
isotypeswitch
bmem
asc
phare
et
al
asc
recruit
directli
brain
spinal
cord
depend
manner
marqu
et
al
although
initi
percentag
asc
within
total
b
cell
similar
brain
spinal
cord
asc
accumul
faster
higher
percentag
spinal
cord
viral
persist
phare
et
al
igg
bmem
emerg
brain
phare
et
al
rel
recruit
spinal
cord
specif
potenti
local
convers
asc
remain
unknown
distinct
express
pattern
among
cn
infiltr
b
cell
rel
slt
counterpart
limit
bmem
identif
flow
cytometri
furthermor
vitro
bmem
stimul
protocol
optim
splenocyt
fail
convert
cn
bmem
suggest
cnsderiv
bmem
succumb
cell
death
support
reduc
preexist
asc
use
similar
cultur
condit
compar
direct
ex
vivo
elispot
asc
comparison
agonist
bmem
activ
supplement
feeder
well
reduc
cultur
length
reveal
optim
cnsderiv
bmem
convers
achiev
day
stimul
agonist
irradi
splenocyt
feeder
bmem
analysi
jhmv
infect
indic
bmem
accumul
promin
chronic
infect
similar
asc
reveal
similar
igg
secret
level
asc
howev
ratio
asc
bmem
invert
compar
brain
spinal
cord
overal
protocol
provid
optim
assay
defin
bmem
specif
quantiti
isotyp
within
inflam
cn
tissu
wild
type
wt
mice
purchas
nation
cancer
institut
frederick
md
sixto
sevenweek
old
mice
infect
intracrani
plaqu
form
unit
pfu
gliatrop
monoclon
ab
deriv
variant
jhmv
design
fleme
et
al
cell
isol
brain
spinal
cord
use
vitro
stimul
elispot
assay
immun
splenic
b
cell
analysi
six
sevenweekold
mice
inject
intraperiton
ip
ml
jhmv
dm
pfuml
anim
procedur
approv
institut
anim
care
use
committe
cleveland
clinic
conduct
complianc
guid
care
use
laboratori
anim
nation
research
council
mice
perfus
transcardi
pb
cleveland
clinic
research
institut
cell
servic
core
cleveland
oh
prior
decapit
skin
remov
expos
skull
midlin
incis
made
skull
remov
resect
brain
follow
brain
dissect
dorsal
skin
along
spinal
column
remov
cut
spinal
column
level
iliac
crest
spinal
cord
flush
caudal
open
spinal
column
pb
use
ml
syring
gaug
needl
mononuclear
cell
spleen
brain
spinal
cord
isol
pool
organ
mice
per
time
point
spleen
dissoci
mechan
red
blood
cell
lyse
cell
isol
brain
spinal
cord
tissu
minc
digest
ml
rpmi
cleveland
clinic
research
institut
cell
servic
core
cleveland
oh
supplement
fetal
calf
serum
fc
hyclon
logan
utah
l
collagenas
type
mgml
worthington
biochem
corpor
lakewood
nj
l
dnase
mgml
roch
indianapoli
min
c
collagenas
activ
termin
addit
edta
ph
c
min
follow
centrifug
cell
resuspend
rpmi
supplement
fc
adjust
percol
ge
healthcar
life
scienc
pittsburgh
pa
underlay
percol
centrifug
min
mononuclear
cell
recov
percol
interfac
wash
rpmi
supplement
fc
cell
subject
flow
cytometr
analysi
resuspend
fluorescentactiv
cell
sorter
fac
buffer
pb
bovin
serum
albumin
wherea
cell
vitro
stimul
resuspend
rpmi
contain
mm
lglutamin
mm
nonessenti
amino
acid
mm
sodium
pyruv
gml
gentamicin
fc
rpmi
complet
cell
incub
fac
buffer
supplement
mix
serum
contain
mous
serum
thermo
fisher
scientif
waltham
goat
serum
atlanta
biolog
floweri
branch
ga
hors
serum
vector
laboratori
youngstown
oh
l
rat
antimous
mab
bd
bioscienc
san
jose
ca
per
cell
min
ice
prior
stain
express
cell
surfac
marker
determin
stain
ice
min
ab
specif
bd
bioscienc
san
jose
ca
igm
pe
igd
apc
pe
ebiosci
san
diego
ca
cell
analyz
bd
lsrii
flow
cytomet
bd
bioscienc
san
jose
ca
use
flowjo
version
softwar
tree
star
ashland
doublet
exclus
live
gate
appli
previous
describ
disano
et
al
dead
cell
compris
less
total
sc
brain
cell
result
plot
repres
independ
experi
splenocyt
mice
use
feeder
layer
b
cell
stimul
follow
red
blood
cell
lysi
wash
resuspend
splenocyt
irradi
dose
rad
use
shepherd
irradi
jl
shepherd
associ
san
fernando
ca
stimul
viral
lysat
splenocyt
ml
rpmi
complet
mix
ml
jhmv
lysat
pfuml
incub
h
h
c
prior
irradi
irradi
feeder
without
viral
lysat
wash
three
time
g
min
resuspend
cell
ml
rpmi
complet
rpmi
complet
contain
either
gml
cpg
gml
invivogen
san
diego
ca
supplement
ngml
recombin
mous
biolegend
san
diego
ca
feeder
variou
stimul
agent
plate
flatbottom
tissu
cultur
plate
corn
tewksburi
block
prolifer
stimul
cn
deriv
effector
cell
cell
suspens
also
irradi
rad
wash
resuspend
rpmi
complet
prior
stimul
effector
cell
cln
spleen
brain
spinal
cord
jhmv
infect
wt
mice
resuspend
start
concentr
pape
et
al
taylor
et
al
cell
per
ml
rpmi
complet
contain
gml
cpg
gml
without
ngml
respect
twofold
dilut
well
per
dilut
total
well
per
condit
plate
flatbottom
tissu
cultur
plate
contain
irradi
feeder
splenocyt
incub
h
day
c
co
stimul
cell
wash
three
time
ml
prewarm
c
rpmi
complet
per
well
centrifug
g
min
last
wash
cell
resuspend
ml
rpmi
complet
per
well
transfer
elispot
plate
jhmvspecif
igg
asc
measur
elispot
assay
previous
describ
disano
et
al
briefli
pvdf
multiscreen
ht
ip
plate
emd
millipor
billerica
coat
jhmv
dm
pfuwel
overnight
c
serial
dilut
cell
plate
triplic
incub
h
c
co
asc
detect
sequenti
incub
biotinyl
rabbit
antimous
igg
gml
southern
biotech
birmingham
al
overnight
c
streptavidin
horseradish
peroxidas
bd
bioscienc
st
loui
mo
h
room
temperatur
filter
diaminobenzidin
substrat
sigmaaldrich
st
loui
mo
hydrogen
peroxid
brown
spot
visibl
within
min
reaction
termin
use
cold
tap
water
spot
count
use
immunospot
elispot
reader
cellular
technolog
ltd
shaker
height
oh
minimum
maximum
spot
size
cutoff
set
mm
mm
respect
spot
analyz
use
diffus
process
spot
separ
size
follow
autom
count
well
recount
manual
exclus
artifact
well
contain
spot
score
posit
virusspecif
asc
analysi
well
within
linear
dilut
rang
averag
stimul
condit
data
analyz
use
prism
version
softwar
graphpad
statist
signific
experiment
group
assess
use
twotail
pair
ttest
case
p
valu
consid
signific
data
repres
experi
pool
mice
per
experi
sever
phenotyp
marker
describ
distinguish
murin
bmem
matur
b
cell
subset
lymphoid
organ
includ
anderson
et
al
tomayko
et
al
howev
previou
compar
analysi
tempor
match
cervic
lymph
node
cln
cn
b
cell
subset
express
activ
marker
gc
b
cell
marker
reveal
distinct
pattern
disano
et
al
exampl
larger
fraction
sever
cn
b
cell
phenotyp
express
compar
peripher
counterpart
express
sustain
unlik
transient
express
cln
suggest
convent
phenotyp
pattern
character
b
cell
subset
includ
bmem
slt
insuffici
reliabl
mark
similar
subset
cn
therefor
ask
common
marker
murin
bmem
within
slt
show
similar
express
pattern
b
cell
deriv
cln
versu
brain
viral
encephalomyel
transmembran
receptor
involv
apoptosi
activ
differenti
prolifer
santosargumedo
highli
express
matur
b
cell
downregul
activ
express
lowest
gc
b
cell
isotypeswitch
asc
contrast
isotypeswitch
bmem
exhibit
promin
express
express
gc
independ
igm
bmem
unclear
anderson
et
al
ridderstad
tarlinton
santosargumedo
distinct
express
surfac
glycoprotein
regul
extracellular
atp
adenosin
level
low
b
cell
upregul
antigen
experienc
gc
b
cell
conter
et
al
express
slt
delin
sever
subpopul
bmem
absent
amongst
plasmablast
plasma
cell
conter
et
al
tomayko
et
al
hi
b
cell
brain
day
pi
well
four
distinct
differenti
subset
defin
surfac
ig
matur
b
cell
igd
igm
activ
b
cell
igd
int
igm
pregcgcisotypeunswitch
igd
igm
bmem
isotypeswitch
bmemasc
igd
igm
thu
compar
analog
cln
day
pi
subset
express
fig
time
point
chosen
reflect
abund
b
cell
subset
respect
organ
fig
show
repres
gate
strategi
four
popul
b
cell
repres
region
activ
b
cell
region
igd
igm
bmem
region
isotypeswitch
bmemasc
region
analysi
focus
day
pi
gc
format
cln
promin
day
pi
differenti
isotypeswitch
b
cell
domin
less
differenti
b
cell
brain
jhmv
persist
phare
et
al
disano
et
al
consist
minor
popul
b
cell
form
gc
thu
predomin
igd
igm
b
cell
popul
cln
throughout
infect
fig
disano
et
al
vast
major
total
cln
b
cell
express
day
pi
fig
express
mark
b
cell
progress
decreas
b
cell
transit
isotypeswitch
phenotyp
fig
express
cell
reduc
igd
int
igm
b
cell
igd
igm
pregcgc
b
cell
igd
igm
isotypeswitch
cell
fig
popul
respect
panel
compris
rel
small
proport
cell
within
cln
disano
et
al
brain
b
cell
reveal
overal
reduc
express
compar
cln
fig
igd
igm
b
cell
also
express
smaller
proport
differenti
cell
downregul
compar
cln
counterpart
although
express
progress
lower
rel
popul
activ
igd
int
igm
pregcisotypeunswitch
bmem
igd
igm
isotypeswitch
b
cell
igd
igm
percentag
cell
remain
even
isotypeswitch
popul
fig
pattern
express
even
divers
b
cell
subset
cln
brain
fig
e
cln
proport
cell
total
cell
coincid
spars
express
igd
igm
b
cell
express
remain
low
igd
int
igm
b
cell
fig
increas
igd
igm
cell
proport
cell
highest
isotypeswitch
igd
igm
b
cell
profil
consist
upregul
antigen
experienc
gc
b
cell
conter
et
al
rel
cln
express
higher
among
cn
infiltr
b
cell
reflect
higher
proport
activ
isotypeswitch
b
cell
accumul
cn
persist
howev
except
b
cell
differ
regul
correspond
b
cell
subpopul
within
brain
fig
igd
int
igm
b
cell
segreg
popul
low
expressor
high
expressor
igd
igm
b
cell
also
split
nonexpress
express
phenotyp
although
express
level
slightli
lower
igd
int
igm
b
cell
isotypeswitch
igd
igm
b
cell
exhibit
even
pronounc
declin
proport
intens
express
fig
whether
distinct
pattern
express
cn
versu
cln
b
cell
reflect
preferenti
recruit
local
influenc
remain
unclear
nevertheless
data
clearli
indic
activ
bmem
marker
character
b
cell
subset
lymphoid
tissu
suitabl
identifi
cn
b
cell
subset
cultur
condit
design
quantifi
virusspecif
bmem
larg
optim
use
cell
deriv
lymphoid
tissu
reli
variou
vitro
stimul
strategi
convert
bmem
asc
measur
elispot
separ
plate
vitro
process
requir
prolifer
thu
prolong
stimul
h
minimum
time
requir
trigger
divis
bmem
slifka
ahm
instanc
follow
lcmv
infect
maxim
virusspecif
bmem
convers
asc
initi
achiev
stimul
splenocyt
lcmv
infect
mice
serial
dilut
irradi
lcmv
infect
carrier
splenocyt
sourc
viral
antigen
day
pi
slifka
ahm
although
vitro
stimul
often
reli
nonspecif
polyclon
activ
infect
cell
often
provid
insuffici
antigen
stimulu
specif
antigen
stimul
select
minim
excess
b
cell
prolifer
bystand
ab
product
irrelev
antigen
hebei
et
al
appli
virusspecif
vitro
stimul
lda
jhmv
infect
initi
infect
mice
ip
harvest
splenocyt
day
pi
stimul
serial
cell
dilut
flat
bottom
cultur
plate
irradi
feeder
preincub
viral
lysat
day
c
vitro
stimul
wash
remov
viru
antibodi
cell
transfer
virusco
elispot
membran
plate
incub
c
h
detect
virusspecif
igg
asc
asc
quantifi
stimul
reflect
preexist
asc
asc
deriv
bmem
quantifi
preexist
asc
serial
splenocyt
dilut
subject
direct
ex
vivo
h
elispot
assay
decreas
asc
frequenc
follow
incub
viral
lysat
day
rel
day
data
shown
reveal
day
stimul
optim
asc
surviv
bmem
convers
follow
peripher
jhmv
infect
howev
splenocyt
stimul
feeder
preincub
viral
lysat
alon
increas
asc
frequenc
rel
ex
vivo
elispot
analysi
fig
result
suggest
viral
lysat
provid
insuffici
stimul
mediat
bmem
convers
bmem
prolifer
convers
asc
stimul
use
pokewe
mitogen
pwm
tlr
agonist
includ
synthet
oligonucleotid
cpg
agonist
agonist
select
convert
bmem
b
cell
asc
cao
et
al
pinna
et
al
jahnmatz
et
al
walsh
et
al
crotti
et
al
hawkin
et
al
therefor
initi
use
cpg
common
polyclon
activ
specif
enhanc
convers
splenic
bmem
b
cell
jhmv
immun
mice
cpg
ad
either
irradi
feeder
alon
feeder
preincub
viral
lysat
stimul
jhmv
bmem
day
describ
elispot
analysi
reveal
day
stimul
superior
day
achiev
highest
asc
frequenc
data
shown
furthermor
optim
cpg
mediat
bmem
asc
convers
independ
viral
lysat
fig
virusspecif
igg
asc
frequenc
higher
follow
stimul
compar
direct
ex
vivo
elispot
analysi
lastli
splenocyt
cpg
stimul
fig
bmem
marker
cn
infiltr
b
cell
distinct
surfac
express
peripheri
brain
cln
cell
isol
pool
organ
jhmv
infect
mice
day
cln
day
brain
pi
analyz
express
repres
gate
strategi
infiltr
b
cell
brain
gate
igd
igm
subset
brain
cln
repres
densiti
plot
depict
bc
de
express
among
total
igd
igm
igd
igm
isotyp
switch
b
cell
within
cln
b
brain
c
e
repres
histogram
depict
express
among
igd
igm
activ
igd
int
igm
igd
igm
isotypeswitch
ascbmem
igd
igm
b
cell
within
cln
brain
data
repres
independ
experi
spinal
cord
c
infect
mice
day
pi
stimul
day
variou
condit
includ
cpg
irradi
feeder
preincub
viral
lysat
cpg
irradi
feeder
cpg
irradi
feeder
preincub
viral
lysat
cultur
virusspecif
igg
secret
asc
enumer
elispot
use
viru
coat
plate
preexist
asc
number
determin
h
h
direct
ex
vivo
elispot
data
repres
mean
sem
asc
per
cell
base
cell
plate
prior
cpg
stimul
pool
mice
asc
frequenc
per
anim
determin
use
averag
frequenc
well
show
spot
within
linear
dilut
rang
data
repres
independ
experi
signific
differ
condit
h
day
indic
p
p
p
p
day
absenc
feeder
decreas
asc
recoveri
compar
direct
ex
vivo
elispot
analysi
suggest
feeder
provid
surviv
factor
vitro
stimul
method
use
jhmv
immun
splenocyt
appli
analyz
virusspecif
igg
bmem
brain
spinal
cord
follow
intracrani
jhmv
infect
moreov
surfac
igg
b
cell
indic
bmem
detect
day
pi
persist
jhmv
infect
phare
et
al
examin
bmem
specif
singl
cell
suspens
brain
spinal
cord
day
pi
serial
dilut
stimul
optim
condit
previous
determin
splenic
b
cell
use
cpg
day
presenc
irradi
feeder
without
viral
lysat
cell
transfer
elispot
plate
assess
virusspecif
igg
asc
fig
focus
igg
vast
major
isotyp
switch
viru
specif
asc
cn
secret
igg
isotyp
ab
minor
contribut
iga
secret
asc
tschen
et
al
preexist
virusspecif
asc
measur
direct
h
ex
vivo
elispot
assay
contrast
splenocyt
neither
brain
spinal
cord
cell
reveal
bmem
asc
convers
indic
increas
spot
rel
number
obtain
direct
ex
vivo
elispot
analysi
find
independ
addit
viral
lysat
rather
increas
virusspecif
asc
cpg
stimul
actual
lower
brain
asc
lower
sc
asc
rel
preexist
asc
fig
c
suggest
cell
death
strong
stimul
prolong
cultur
cn
cell
loss
washingtransf
procedur
lead
prematur
attrit
preexist
asc
support
studi
lcmv
suggest
direct
ex
vivo
asc
assay
may
yield
higher
asc
frequenc
observ
prolong
cultur
therebi
complic
calcul
potenti
underestim
asc
convert
bmem
slifka
ahm
discrep
bmem
convers
stimul
spleen
versu
cn
impli
cn
environ
sustain
bmem
asc
surviv
surviv
limit
explant
therefor
assess
distinct
vitro
stimul
condit
includ
tlr
agonist
cpg
affect
cn
deriv
preexist
virusspecif
igg
asc
minim
cell
death
due
prolong
cultur
incub
limit
day
increas
asc
frequenc
compar
day
stimul
initi
studi
data
shown
preexist
asc
measur
serial
dilut
cnsderiv
cell
day
pi
use
four
condit
direct
ex
vivo
h
elispot
b
stimul
cpg
h
insuffici
time
bmem
differenti
asc
slifka
ahm
c
stimul
cpg
supplement
feeder
day
irradi
cn
cell
block
cellular
divis
slifka
ahm
lastli
cultur
splenocyt
feeder
cell
day
assess
whether
feederderiv
supplement
sustain
preexist
asc
follow
distinct
cultur
condit
serial
dilut
cell
transfer
elispot
membran
assess
virusspecif
igg
asc
h
later
asc
obtain
vitro
stimul
control
compar
preexist
asc
obtain
direct
ex
vivo
elispot
fig
fig
includ
data
stimul
cpg
stimul
produc
interchang
result
data
shown
h
cultur
alreadi
reduc
asc
frequenc
rel
ex
vivo
asc
number
brain
spinal
cordderiv
cell
howev
day
stimul
condit
reduc
preexist
asc
number
cultur
condit
yield
preexist
asc
within
brain
within
spinal
cord
repres
reduct
compar
direct
asc
assay
consist
control
result
suggest
multipl
wash
step
transfer
elispot
membran
reduc
asc
recoveri
importantli
differ
vitro
control
abrog
bmem
convers
result
similar
virusspecif
igg
asc
demonstr
reproduc
calcul
preexist
asc
exposur
preexist
asc
cultur
condit
bmem
thu
underestim
asc
provid
valid
approach
assess
asc
deriv
bmem
convers
rel
preexist
asc
comparison
asc
number
obtain
direct
ex
vivo
elispot
optim
cn
deriv
bmem
convers
next
examin
effect
tlr
agonist
cpg
variou
cultur
condit
use
cn
cell
persist
infect
mice
day
pi
stimul
human
pbmc
murin
splenocyt
recent
shown
enhanc
bmem
convers
compar
cpg
stimul
suggest
may
superior
stimul
agent
jahnmatz
et
al
bmem
convers
evalu
rel
preexist
asc
number
obtain
irradi
cn
cell
stimul
day
condit
fig
expect
feeder
cell
show
detect
asc
even
cultur
tlr
agonist
fig
fig
vitro
stimul
protocol
reduc
asc
number
cell
isol
brain
spinal
cord
infect
mice
day
pi
stimul
h
day
presenc
irradi
splenocyt
feeder
indic
direct
ex
vivo
asc
quantif
conduct
use
h
incub
elispot
plate
h
asc
control
cn
cell
cultur
splenocty
feeder
stimul
day
asc
control
splenocyt
feeder
cultur
irradi
cn
cell
stimul
cn
cell
without
stimul
cultur
virusspecif
igg
secret
asc
enumer
elispot
use
viru
coat
plate
data
repres
mean
sem
asc
per
cell
prior
stimul
pool
mice
asc
frequenc
per
anim
determin
use
averag
frequenc
well
show
spot
within
linear
dilut
rang
data
repres
independ
experi
cocultur
brainderiv
cell
feeder
alon
improv
recoveri
virusspecif
asc
rel
feeder
support
feeder
provid
surviv
factor
howev
feeder
significantli
enhanc
asc
frequenc
spinal
cordderiv
b
cell
fig
suggest
may
less
prone
death
brain
counterpart
cpg
stimul
result
modest
increas
virusspecif
asc
brain
deriv
spinal
cordderiv
cell
compar
feeder
alon
contrast
stimul
significantli
increas
virusspecif
asc
rel
preexist
asc
brain
spinal
cord
cell
irradi
cn
effector
cell
reduc
cpg
asc
frequenc
back
feeder
cultur
fre
fig
day
stimul
provid
optim
asc
convers
cnsderiv
bmem
cell
isol
brain
spinal
cord
infect
mice
day
pi
incub
irradi
feeder
plu
cpg
day
indic
b
cell
isol
brain
spinal
cord
infect
mice
day
pi
stimul
cpg
without
presenc
irradi
splenocyt
feeder
day
cultur
virusspecif
igg
secret
asc
enumer
elispot
use
viru
coat
plate
data
repres
mean
sem
asc
per
cell
base
cell
plate
prior
stimul
pool
mice
asc
frequenc
per
anim
determin
use
averag
frequenc
well
show
spot
within
linear
dilut
rang
data
repres
independ
experi
signific
differ
condit
panel
indic
p
p
p
panel
b
signific
differ
compar
condit
either
day
day
indic
p
p
p
respect
signific
differ
compar
condit
day
indic
p
quenci
fig
result
confirm
increas
asc
frequenc
follow
tlr
stimul
inde
result
bmem
prolifer
convers
importantli
bmem
prolifer
initi
h
day
stimul
period
limit
prolifer
divis
therebi
minim
artifici
high
bmem
frequenc
due
numer
divis
slifka
ahm
tangy
hodgkin
bernasconi
et
al
supplement
media
either
use
cona
condit
medium
recombin
shown
enhanc
cell
surviv
bmem
convers
vitro
bmem
stimul
assay
slifka
ahm
walsh
et
al
test
whether
cn
bmem
convers
could
increas
expand
stimul
time
day
supplement
media
howev
neither
increas
cultur
durat
addit
cpg
stimul
enhanc
bmem
asc
convers
brain
deriv
cell
independ
stimul
day
fig
furthermor
improv
asc
recoveri
day
day
cultur
cpg
stimul
spinal
cord
cell
prolong
cultur
time
modestli
increas
brain
deriv
virusspecif
asc
follow
stimul
addit
enhanc
effect
prolong
stimul
also
benefici
effect
bmem
convers
stimul
spinal
cord
cell
modestli
increas
asc
day
stimul
overal
result
confirm
superior
stimul
compar
cpg
independ
prolong
cultur
addit
therefor
chose
stimul
day
optim
bmem
convers
cn
deriv
cell
jhmv
infect
induc
virusspecif
igg
asc
expans
within
drain
cervic
lymph
node
cln
day
pi
coincid
preexist
asc
number
calcul
stimul
irradi
cn
cell
incub
splenocyt
feeder
bmem
number
calcul
base
total
asc
number
stimul
minu
preexist
asc
number
data
repres
mean
sem
asc
per
cell
base
cell
plate
prior
nonspecif
stimul
pool
mice
mean
valu
calcul
well
show
spot
within
linear
dilut
rang
two
independ
experi
reveal
similar
ascbmem
kinet
throughout
infect
c
spot
size
brain
spinal
cordderiv
asc
follow
direct
ex
vivo
h
incub
asc
h
day
stimul
count
highlight
asc
count
day
stimul
gc
format
disano
et
al
tschen
et
al
virusspecif
igg
initi
accumul
brain
spinal
cord
preferenti
increas
spinal
cord
site
viral
persist
low
ongo
inflamm
phare
et
al
increas
viru
specif
igg
spinal
cord
day
pi
correl
overal
increas
fraction
asc
compar
brain
phare
et
al
phare
et
al
use
assay
condit
optim
assess
bmem
number
rel
asc
cn
jhmv
infect
onset
asc
emerg
day
persist
day
pi
tschen
et
al
reproduc
kinet
virusspecif
igg
bmem
preexist
asc
evalu
brain
spinal
cord
independ
experi
fig
b
biolog
variabl
immun
respons
infect
effici
cn
cell
isol
lead
differ
absolut
frequenc
multipl
experi
preexist
asc
calcul
use
averag
well
linear
dilut
rang
irradi
cn
cell
cultur
feeder
virusspecif
igg
bmem
calcul
subtract
averag
preexist
asc
averag
number
asc
obtain
stimul
virusspecif
asc
progress
accumul
within
cn
persist
elev
frequenc
spinal
cord
day
pi
confirm
previou
result
phare
et
al
tschen
et
al
virusspecif
bmem
frequenc
brain
compar
asc
day
pi
cell
increas
day
pi
fig
b
furthermor
bmem
surpass
asc
frequenc
brain
day
pi
spinal
cord
also
reveal
similarli
low
frequenc
bmem
asc
day
pi
increas
day
pi
although
increas
rel
day
pi
rang
virusspecif
asc
frequenc
overal
higher
bmem
ratio
asc
bmem
brain
invert
spinal
cord
averag
result
separ
experi
furthermor
contrast
preferenti
accumul
asc
spinal
cord
chronic
infect
bmem
similar
within
brain
spinal
cord
day
pi
remain
unclear
whether
site
enhanc
viral
persist
preferenti
affect
asc
bmem
accumul
whether
spinal
cord
environ
mediat
local
convers
bmem
asc
detect
virusspecif
bmem
cn
led
us
examin
bmem
deriv
asc
igg
secret
capac
compar
preexist
asc
spot
diamet
intens
reflect
ig
secret
rate
affin
larg
intens
spot
indic
differenti
high
affin
asc
sibley
et
al
thomson
fesk
et
al
karulin
lehmann
therefor
investig
ig
secret
quantifi
spot
size
virusspecif
igg
deriv
convert
asc
day
stimul
versu
preexist
asc
direct
ex
vivo
elispot
henn
et
al
addit
control
asc
spot
size
h
stimul
compar
control
effect
vitro
stimul
preexist
asc
spot
size
fig
quantif
reveal
signific
differ
asc
spot
size
h
stimul
versu
direct
ex
vivo
elispot
data
shown
importantli
virusspecif
igg
spot
size
brain
deriv
asc
measur
directli
ex
vivo
elispot
assay
asc
form
day
post
stimul
also
similar
mean
spot
size
fig
similarli
spot
size
analysi
spinal
cordderiv
cell
reveal
signific
differ
asc
stimul
compar
direct
ex
vivo
elispot
nevertheless
mean
spot
size
suggest
enhanc
igg
secret
asc
well
mean
sem
asc
spot
size
follow
direct
ex
vivo
elispot
asc
asc
day
stimul
brain
spinal
cord
sc
data
repres
independ
experi
signific
differ
brain
spinal
cord
indic
p
p
bmem
spinal
cord
rel
brain
fig
vitro
stimul
assay
establish
cn
deriv
bmem
therefor
use
tool
quantifi
determin
bmem
specif
adapt
assess
isotyp
variant
ig
secret
level
heterolog
cn
inflamm
model
presenc
b
cell
multipl
differenti
phenotyp
cn
follow
variou
insult
includ
infect
reinvigor
research
mechan
support
accumul
function
specif
recruit
asc
cn
specif
follow
viral
encephalomyel
well
document
anim
model
tschen
et
al
metcalf
et
al
asc
also
detect
csf
patient
afflict
viral
enceph
multipl
sclerosi
krumbholz
et
al
burk
et
al
jacobi
et
al
kapoor
et
al
linnoila
et
al
skoldenberg
et
al
howev
presenc
bmem
specif
studi
extens
due
methodolog
limit
determin
specif
bmem
requir
minim
stimul
convert
asc
compar
b
cell
kurosaki
et
al
ideal
candid
local
differenti
sustain
ab
respons
persist
antigen
helper
cell
cytokin
tlr
agonist
present
inflam
cn
potenti
induc
bmem
differenti
asc
kurosaki
et
al
hebei
et
al
aiba
et
al
geffroyluseau
et
al
viral
enceph
antigen
specif
bmem
may
local
contribut
humor
respons
serv
protect
role
control
infecti
viru
howev
bmem
direct
selfantigen
neurodegener
autoimmun
injuri
may
enhanc
pathogen
respons
jhmv
induc
acut
encephalomyel
resolv
persist
provid
excel
model
studi
progress
mainten
humor
respons
within
cn
accumul
isotypeswitch
igg
b
cell
characterist
bmem
brain
spinal
cord
persist
infect
led
us
assess
specif
use
establish
bmem
asc
convers
protocol
develop
b
cell
lymphoid
organ
howev
sever
unsuccess
trial
appli
procedur
cn
b
cell
prompt
us
tailor
cultur
condit
enhanc
bmem
asc
convers
well
preexist
asc
surviv
yield
high
number
viabl
cn
cell
retain
classic
b
cell
surfac
marker
protocol
use
collagenasebas
digest
cn
tissu
initi
lda
vitro
cultur
condit
mainli
differ
lda
stimul
protocol
util
shorter
mediat
stimul
period
circumv
b
cell
loss
presum
due
cell
death
moreov
addit
irradi
feeder
cell
improv
surviv
ascbmem
supplement
benefici
effect
although
shorten
day
stimul
period
minim
cell
death
signific
cell
loss
wash
transfer
process
evid
similar
reduct
preexist
asc
h
day
stimul
compar
direct
ex
vivo
elispot
although
ex
vivo
stimul
directli
elispot
membran
thu
appear
ideal
minim
cell
loss
prolong
incub
cell
elispot
membran
lead
increas
background
artefact
due
cell
debri
increas
spot
densiti
due
high
level
ab
secret
obviou
caveat
vitro
stimul
well
flat
bottom
cultur
plate
thu
bmem
asc
frequenc
may
underestim
indic
control
experi
preexist
asc
vitro
stimul
control
inhibit
bmem
convers
thu
necessari
standard
cell
loss
compar
ratio
bmem
preexist
asc
anoth
caveat
bmem
stimul
prior
elispot
analysi
use
polyclon
stimul
tlr
agonist
induc
rapid
prolifer
regardless
antigen
specif
therebi
potenti
overestim
bmem
number
base
asc
convers
vitro
stimul
util
feeder
present
viru
antigen
would
limit
nonspecif
rapid
prolifer
result
accur
assess
virusspecif
bmem
howev
incub
viru
lysat
feeder
insuffici
convert
bmem
system
presum
due
limit
viru
dose
nevertheless
fairli
short
stimul
time
day
addit
use
viru
coat
elispot
plate
limit
prolifer
potenti
skew
virusspecif
igg
asc
within
total
igg
asc
although
futur
studi
aim
optim
stimul
use
feeder
incub
distinct
viral
antigen
induc
physiolog
relev
bmem
convers
caveat
jhmv
system
spike
protein
bind
highli
express
b
cell
signal
molecul
william
et
al
greiciu
et
al
khairnar
et
al
summari
optim
lda
vitro
stimul
elispot
assay
provid
tool
simultan
analysi
cn
deriv
bmem
asc
neuroinflammatori
diseas
includ
microbi
infect
autoimmun
tissu
injuri
rel
short
day
combin
vitro
stimul
ldaelispot
procedur
effici
previous
describ
week
stimul
elisa
base
bmem
assay
measur
secret
ab
assay
allow
assess
bmem
antigen
specif
isotyp
kinet
alter
throughout
diseas
complementari
enumer
bmem
base
surfac
marker
profil
compar
assess
bmem
slt
cn
aid
understand
relationship
peripher
bmem
cn
accumul
diseas
identifi
tissu
specif
therapeut
either
enhanc
diminish
bmem
neuroinflammatori
diseas
